Vanguard Group Inc Equillium, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Equillium, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 841,948 shares of EQ stock, worth $420,974. This represents 0.0% of its overall portfolio holdings.
Number of Shares
841,948
Previous 841,948
-0.0%
Holding current value
$420,974
Previous $665,000
50.68%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding EQ
# of Institutions
30Shares Held
11.3MCall Options Held
13.2KPut Options Held
100-
Decheng Capital LLC Menlo Park, CA4.45MShares$2.22 Million0.49% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$2.22 Million1.82% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$281,139100.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny270KShares$134,7500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA196KShares$98,0450.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $17.2M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...